Logo of The German Trade Office Taipei

Healthcare

Taiwan’s health sector offers a dynamic and innovation-friendly environment with strong government backing, high demand for advanced medical solutions, and seamless access to the Asia-Pacific region. For German companies looking to expand internationally, Taiwan presents both a strategic launchpad and a reliable partner market.

Healthcare
Kzenon/Shutterstock.com
Key Facts & Market Volume
  • Taiwan will become a super-aged society by 2025, with over 20% of the population aged 65+. By 2036, half of the population will be over 50—driving demand for healthcare products and services.
  • In 2025, the government increased its healthcare budget by 5.5% to EUR 26.4 billion, with more funding planned under the “Healthy Taiwan” initiative, focusing on cancer, cardiovascular diseases, biotech, and AI-powered precision medicine.
  • 80% of pharmaceuticals are imported. In 2024, Germany was Taiwan’s largest supplier, with exports worth EUR 5.3 billion and a 22.5% market share.
  • In the medical device sector, Germany ranked fourth, behind the U.S., Japan, and China, with EUR 2.7 billion in exports to Taiwan in 2024 (8.5% share).
  • Taiwan offers a high-quality yet understaffed healthcare system, creating opportunities for digital solutions and automation.

  • 26.4 billion EUR

    in allocated funding

  • 80% of pharamceuticals

    are imported from Germany

  • > 20% aged 65+

    of the population
Important Areas for Collaboration

Medical Devices & Diagnostics:

Opportunities for German precision engineering, imaging systems, and diagnostics.

Biotech & Pharmaceuticals

Joint R&D, biosimilars, and clinical trial partnerships.

Elder Care & Assistive Tech

Rising demand driven by an aging population—German expertise is highly valued.

Digital Health & AI

Taiwan’s push for smart healthcare aligns with Germany’s strengths in medtech and data-driven care.

AI diagnostics
AI-generated/freepik.com
Latest Trends

Taiwan is advancing rapidly in smart healthcare, driven by digitalization, aging demographics, and strong ICT capabilities. From AI-assisted diagnostics and telehealth platforms to sustainable hospital solutions and integrated data systems, the focus is on efficiency, personalization, and global collaboration. Public-private partnerships and government-backed pilots create a fertile ground for foreign companies with innovative offerings.

Potential for German Companies

Taiwan presents substantial potential and a dynamic, innovation-driven environment for German companies in the healthcare sector. Products "Made in Germany" enjoy an excellent reputation, and Taiwanese consumers are often willing to pay a premium for this recognized standard of quality. The market is especially attractive for German manufacturers of traditional pharmaceuticals and medical devices. In addition, there are growing opportunities for providers of precision medicine solutions—particularly those leveraging artificial intelligence and big data to deliver personalized diagnostic and therapeutic approaches.

Key Players & Partners active in Taiwan

German Companies:

Taiwanese Players:

Innovation Hubs:

Siemens Healthineers

 

B. Braun 

 

Dräger

 

Sartorius

TaiDoc

 

CHC Healthcare Group

 

PharmaEssentia

 

ACT Genomics

National Biotechnology Research Park (NBRP)

 

Taipei Medical University & TMU BioMed Accelerator

 

Hsinchu Biomedical Science Park

Interested in exploring the Taiwanese healthcare market or finding new business partners? We’ll help you connect with your next business partner.

  • Business Partner Search

    Business Partner Search

    Take advantage of our expertise and find new business partners with us!

Contact